About PERPIGNAN - CH St Jean - Hématologie Clinique
Le centre hospitalier de Perpignan, anciennement hôpital Saint-Jean, est un centre hospitalier situé à Perpignan dans les Pyrénées-Orientales, en région Occitanie.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at PERPIGNAN - CH St Jean - Hématologie Clinique
During the past decade, PERPIGNAN - CH St Jean - Hématologie Clinique conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "PERPIGNAN - CH St Jean - Hématologie Clinique"
#1 collaborator was "AbbVie" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "BeiGene" with 1 trials as a collaborator and "Janssen-Cilag Ltd." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at PERPIGNAN - CH St Jean - Hématologie Clinique
According to Clinical.Site data, the most researched conditions in "PERPIGNAN - CH St Jean - Hématologie Clinique" are
"Acute Myeloid Leukemia" (1 trials) and "CLL/SLL" (1 trials). Many other conditions were trialed in "PERPIGNAN - CH St Jean - Hématologie Clinique" in a lesser frequency.
Clinical Trials Intervention Types at PERPIGNAN - CH St Jean - Hématologie Clinique
Most popular intervention types in "PERPIGNAN - CH St Jean - Hématologie Clinique" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Cytarabine-Idarubicin Association" (1 trials), "Cytarabine-Venetoclax Association" (1 trials) and "First line therapy" (1 trials). Other intervention names were less common.
Clinical Trials Genders at PERPIGNAN - CH St Jean - Hématologie Clinique
The vast majority of trials in "PERPIGNAN - CH St Jean - Hématologie Clinique" are
2 trials for "All" genders.
Clinical Trials Status at PERPIGNAN - CH St Jean - Hématologie Clinique
Currently, there are NaN active trials in "PERPIGNAN - CH St Jean - Hématologie Clinique".
undefined are not yet recruiting,
2 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in PERPIGNAN - CH St Jean - Hématologie Clinique,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in PERPIGNAN - CH St Jean - Hématologie Clinique, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".